Erratum: Equivalence of glatiramer acetate generics with branded glatiramer acetate in efficacy and cost for the treatment of multiple sclerosis (JAMA Neurol. (2015) 1-3 10.1001/jamaneurol.2015.2605)

Dennis Bourdette, D. Hartung

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1537
Number of pages1
JournalJAMA Neurology
Volume72
Issue number12
DOIs
StatePublished - Dec 1 2015

ASJC Scopus subject areas

  • Clinical Neurology

Cite this